Cancer doctors are welcoming the funding of 13 new cancer drugs, but say with potentially 175,000 cancer patients getting them in the first year, the system for administering them won’t cope. Read more
Does access to medicines differ from access to healthcare? Experiences of barriers to medicines access by people facing social disadvantage
Levesque et al.’s widely-cited five dimensional model of access to healthcare has been used in a variety of contexts, including access to medicines.





